MIT Technology Review
This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
Unlimited Bio is developing gene therapies for muscle growth, erectile dysfunction, and radical longevity, with plans to inject volunteers with experimental treatments. The company aims to enhance strength, endurance, and recovery through muscle injections and is also exploring therapies for baldness and erectile dysfunction. Concerns have been raised about the safety and effectiveness of these gene therapies, as they target healthy individuals. While the trials may provide insights into the therapies' effects, experts caution against unrealistic expectations and emphasize the need for rigorous clinical data.
MIT Technology Review•